SCHEMBL2371289

SCHEMBL2371289

COc1ccc(CC(=O)O)cc1OC1CCCC1

nearest known ligand 0.60

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 12/20 0.60
PDE4A P27815 11/20 0.60
PDE4D Q08499 10/20 0.60
PDE4C Q08493 9/20 0.60
GAA P10253 2/20 0.56
ALDH1A1 P00352 1/20 0.56
TSHR P16473 1/20 0.56
NFKB1 P19838 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
POLB P06746 1/20 0.54
CA5A P35218 1/20 0.53
MAPK14 Q16539 1/20 0.52
RECQL P46063 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31661693 0.94 RECQL (0.58) PDE4BPDE4APDE4DPDE4CGAA
SCHEMBL6366618 0.94 RECQL (0.58) PDE4BPDE4APDE4DPDE4CGAA
SCHEMBL5022264 0.92 CA5A (0.57) PDE4BPDE4APDE4DPDE4CGAA
SCHEMBL7023339 0.88 PDE4B (0.55) PDE4BPDE4APDE4DPDE4CPOLB
SCHEMBL7332617 0.88 PDE4B (0.58) PDE4BPDE4APDE4DPDE4CPOLB
SCHEMBL7332241 0.87 PDE4A (0.57) PDE4BPDE4APDE4DPDE4C
SCHEMBL7329994 0.86 POLB (0.55) PDE4BPDE4APDE4DPDE4CPOLB
SCHEMBL7335293 0.86 PDE4A (0.58) PDE4BPDE4APDE4DPDE4CPOLB
SCHEMBL7340266 0.85 PDE4B (0.53) PDE4BPDE4APDE4DPDE4CPOLB
SCHEMBL7420826 0.85 PDE4A (0.57) PDE4BPDE4APDE4DPDE4CPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117658752-A Deuterated 5-phenylpiperidine-2-ketone compound and application thereof 阿斯诺来(上海)医药科技有限公司 2024-03-08 CN disclosed
WO-2011114103-A1 PYRIMIDINONES FOR USE AS MEDICAMENTS BIOLIPOX AB (SE) 2011-09-22 WO disclosed
WO-2010029299-A1 PYRIMIDINONE DERIVATIES FOR USE AS MEDICAMENTS BIOLIPOX AB (SE) 2010-03-18 WO disclosed
US-6372770-B1 TREATING A MAMMAL SUFFERING FROM A DISEASE STATE SELECTED FROM THE GROUP CONSISTING OF ASTHMA, ALLERGIES, INFLAMMATION, DEPRESSION, DEMENTIA, ATOPIC DISEASES, RHINITIS AND DISEASE STATES ASSOCIATED WITH ABNORMALLY HIGH PHYSIOLOGICAL LEVELS OF EURO-CELTIQUE, S.A. 2002-04-16 US disclosed
US-6153630-A Phenylpyridyl compounds for inhibiting phosphodiesterase IV and methods of using same EURO-CELTIQUE, S.A. (LU) 2000-11-28 US disclosed
US-5889014-A ASTHMA, ARTHRITIS, ALLERGIES, INFLAMMATION, DEPRESSION THERAPY EURO-CELTIQUE, S.A. (LU) 1999-03-30 US disclosed
EP-0796093-A4 COMPOUNDS FOR AND METHOD OF INHIBITING PHOSPHODIESTERASE IV EURO CELTIQUE SA (LU) 1998-05-13 EP disclosed
WO-1998005327-A1 SUBSTITUTED AROMATIC COMPOUNDS RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1998-02-12 WO disclosed
EP-0785927-A4 NOVEL BENZOXAZOLES EURO CELTIQUE SA (LU) 1997-12-29 EP disclosed
EP-0796093-A1 COMPOUNDS FOR AND METHOD OF INHIBITING PHOSPHODIESTERASE IV Euroceltique S.A. (LU) 1997-09-24 EP disclosed
US-5665737-A PHOSPHODIESTERASE INHIBITORS EURO-CELTIQUE, S.A. (LU) 1997-09-09 US disclosed
EP-0785927-A1 NOVEL BENZOXAZOLES Euroceltique S.A. (LU) 1997-07-30 EP disclosed
US-5591776-A Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV EURO-CELTIQUE, S.A. (LU) 1997-01-07 US disclosed
WO-1996021435-A1 COMPOUNDS FOR AND METHOD OF INHIBITING PHOSPHODIESTERASE IV EURO-CELTIQUE, S.A. (LU) 1996-07-18 WO disclosed
WO-1996011917-A1 NOVEL BENZOXAZOLES EURO-CELTIQUE, S.A. (LU) 1996-04-25 WO disclosed
EP-0538384-A4 OXAMIDES SMITHKLINE BEECHAM CORP (US) 1995-04-12 EP disclosed
US-5393788-A Phenylalkyl oxamides SMITHKLINE BEECHAM CORPORATION (US) 1995-02-28 US disclosed
EP-0538384-A1 OXAMIDES SMITHKLINE BEECHAM CORPORATION (US) 1993-04-28 EP disclosed
WO-1992000968-A1 OXAMIDES SMITHKLINE BEECHAM CORPORATION (US) 1992-01-23 WO disclosed